January 5, 2023 January 5, 2023Categories Ongoing TrialsOngoing Trial: The INSIGNA clinical trial is testing the timing of immunotherapy alone or with chemotherapy for patients with advanced lung cancerThis trial is seeking to find out whether patients with the PD-L1 biomarker can either delay having chemotherapy or avoid it altogether
December 15, 2021 December 15, 2021Categories Ongoing TrialsOngoing Trial: Clinical trial EA5182 is testing the addition of a drug to the most commonly used first treatment for patients with lung cancer that has spreadThis study is exploring a new treatment option for patients with advanced (metastatic) non-small cell lung cancer that has the EGFR gene mutation
September 20, 2021 September 20, 2021Categories EditorialsThe language of (lung) cancerA new language guide encourages respect, eliminates blame, and promotes health equity
September 20, 2021 September 20, 2021Categories Trial ResultsTrial Results: Recent ECOG-ACRIN researchSummaries of recently reported ECOG-ACRIN research results